Cargando…
CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice
AIMS/HYPOTHESIS: Colony stimulating factor 1 (CSF1) promotes the proliferation, differentiation and survival of macrophages, which have been implicated in both beneficial and detrimental effects on glucose metabolism. However, the physiological role of CSF1 signalling in glucose homeostasis and the...
Autores principales: | Bosch, Angela J. T., Keller, Lena, Steiger, Laura, Rohm, Theresa V., Wiedemann, Sophia J., Low, Andy J. Y., Stawiski, Marc, Rachid, Leila, Roux, Julien, Konrad, Daniel, Wueest, Stephan, Tugues, Sonia, Greter, Melanie, Böni-Schnetzler, Marianne, Meier, Daniel T., Cavelti-Weder, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627931/ https://www.ncbi.nlm.nih.gov/pubmed/37792013 http://dx.doi.org/10.1007/s00125-023-06007-1 |
Ejemplares similares
-
Significant Sex Differences in the Efficacy of the CSF1R Inhibitor-PLX5622 on Rat Brain Microglia Elimination
por: Sharon, Aviv, et al.
Publicado: (2022) -
Putting PLX5622 into perspective: microglia in central nervous system viral infection
por: Spiteri, Alanna G., et al.
Publicado: (2022) -
Reply to Green and Hume: Nonmicroglia peripheral immune effects of short-term CSF1R inhibition with PLX5622
por: Lei, Fengyang, et al.
Publicado: (2021) -
CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice
por: Ali, Seemaab, et al.
Publicado: (2020) -
Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis
por: Mein, Nils, et al.
Publicado: (2023)